Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 6

Results: 38

Ribociclib-induced pulmonary infiltrates in a patient with breast cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1537, doi. 10.1177/10781552231192005

By:

Ünsal, Oktay;
Özet, Ahmet

Publication type:

Article

Poly(ADP-ribose) polymerase inhibitors in the treatment landscape of triple-negative breast cancer (TNBC).

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1467, doi. 10.1177/10781552231188903

By:

El Gazzar, Walaa Bayoumie;
Albakri, Khaled Anwer;
Hasan, Hanan;
Badr, Amira M;
Farag, Amina A;
Saleh, Othman Mohammad

Publication type:

Article

Retraction Notice: Adherence to treatment with oral antineoplastic therapy in outpatients.

Published in:: Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1541, doi. 10.1177/10781552231180699
Publication type:: Article

Azacitidine as a rare cause of reactive arthritis in a patient with acute myeloid leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1533, doi. 10.1177/10781552231180470

By:

Alsaadi, Daniah;
Low, Lyndon;
Zubairu, Mustafa;
Clesham, Kevin;
Rowan, Fiachra

Publication type:

Article

Ribociclib-induced visual hallucination in a patient with metastatic breast cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1529, doi. 10.1177/10781552231180463

By:

Kapagan, Tanju;
Bulut, Nilufer;
Demirer, Serhat;
Erdem, Gokmen Umut

Publication type:

Article

An unusual case of checkpoint-inhibitor-induced pleuropericarditis.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1525, doi. 10.1177/10781552231179369

By:

Suarez, Zoilo K;
Finke, Ana C;
Hospedales, Emilio;
Perez, Ernesto;
Sharifzadeh, Arya;
Foster, Jennifer;
Ferris, Allison

Publication type:

Article

Liver cirrhosis following oxaliplatin-based adjuvant chemotherapy for rectal cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1520, doi. 10.1177/10781552231178685

By:

Huang, Cheng;
Chen, Jv;
Situ, Yongli

Publication type:

Article

FOLFIRI-bevacizumab-induced acute toxic leukoencephalopathy.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1516, doi. 10.1177/10781552231178680

By:

Sertesen, Elif;
Öztaş, Ali;
Karaçin, Cengiz;
Yoloğlu, Zeynel

Publication type:

Article

Combined use of pembrolizumab and lenvatinib: A review.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1461, doi. 10.1177/10781552231178461

By:

Eisinger, Casey;
Muluneh, Benyam

Publication type:

Article

Nivolumab-induced sensory ganglionopathy.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1510, doi. 10.1177/10781552231177712

By:

Coskun, Ozlem;
Sahin, Hasan;
Yalcin, Selim;
Sahin, Yekta C.;
Coskun, Ugur

Publication type:

Article

Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1503, doi. 10.1177/10781552231177597

By:

Xie, LinLin

Publication type:

Article

Extemporaneous compounding of dabrafenib and trametinib for cancer patients with feeding tubes.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1498, doi. 10.1177/10781552231175087

By:

Bui, Trinh;
Vu, Van;
Luon, Darren

Publication type:

Article

Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1494, doi. 10.1177/10781552231174593

By:

Bayram, Doğan;
Aktürk Esen, Selin;
Uçar, Gökhan;
Köş, Fahriye Tuğba

Publication type:

Article

Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1489, doi. 10.1177/10781552231173441

By:

Freydman, Jessica;
Staron, Andrew;
Hughes, David;
Sloan, John M

Publication type:

Article

Severe hepatotoxicity during treatment with capmatinib.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1484, doi. 10.1177/10781552231173120

By:

Valencia Soto, Carmen María;
Martínez Callejo, Virginia;
García-Avello Fernández-Cueto, Adela;
Villacañas Palomares, María Victoria;
Barbadillo Villanueva, Sara;
Ochagavía Sufrategui, María;
López-Brea Piqueras, Marta Francisca;
Valero Domínguez, Marta

Publication type:

Article

Gemcitabine-associated DRESS syndrome: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1480, doi. 10.1177/10781552231167531

By:

Bayram, Ertugrul;
Toyran, Tugba;
Paydas, Semra

Publication type:

Article

Corrigendum to "Anti-cancer medicine shortages in an oncology tertiary hospital of Pakistan: A five-year retrospective study".

Published in:: 2023
Publication type:: Correction Notice

A comparison of hypersensitivity reactions between intravenous and intramuscular applications of native E. coli asparaginase in children with acute lymphoblastic leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1454, doi. 10.1177/10781552231164503

By:

Odaman Al, Işık;
Özdemir, Nihal;
Zengin Ersoy, Gizem;
Bayram, Cengiz;
Vupa Çilengiroğlu, Özgül;
Arslantaş, Esra;
Paslı Uysalol, Ezgi;
Ayçiçek, Ali

Publication type:

Article

Medication errors in cancer therapy: Reports from German hospital pharmacists between 2008 and 2019.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1443, doi. 10.1177/10781552221135130

By:

Weber, Lisa;
Langebrake, Claudia;
Picksak, Gesine;
Schöning, Tilman;
Schulze, Ingo;
Jaehde, Ulrich

Publication type:

Article

Comparative cost savings of biosimilar and dose rounding utilization in oncology care.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1437, doi. 10.1177/10781552221134257

By:

Abdelmeseh, Verona;
Brown, Britny R;
Huynh, Justin P;
Zullo, Andrew R

Publication type:

Article

Management of chemotherapy-induced febrile neutropenia and use of granulocyte colony-stimulating factor in patients with soft tissue or bone sarcoma.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1428, doi. 10.1177/10781552221131901

By:

Mazzaro, Raphaele Teixeira;
Vaz, Mahanna Vanzeler;
Badin, Rebeka Caribé;
Bernardina, Eliza Dalla;
Manaças, Liliane Rosa Alves

Publication type:

Article

Economic burden in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with or without brain metastases, receiving first-line ALK inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1418, doi. 10.1177/10781552221126174

By:

Wu, Yanyu;
Ren, Kaili;
Wan, Yin;
Lin, Huamao M

Publication type:

Article

Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1404, doi. 10.1177/10781552221126102

By:

O'Connor, Hannah;
Melanophy, Gail;
Martin, Carlos Medina;
Flattery, Martin;
O'Dea, Edel

Publication type:

Article

Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1398, doi. 10.1177/10781552221125871

By:

Watson, Aleksandra N;
Shah, Shreya A;
Shalhoub, Sila D;
Piedra, Katrina M;
Komanduri, Krishna V;
Kwon, Deukwoo;
Pereira, Denise L

Publication type:

Article

Inpatient utilization of immune checkpoint inhibitors and clinical outcomes.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1392, doi. 10.1177/10781552221123967

By:

Wang, Jonathan;
Lee, Chung-Shien;
Attarian, Shirin;
Kohn, Nina;
Devoe, Craig

Publication type:

Article

Assessment of chemotherapy-related educational needs of colorectal cancer patients.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1387, doi. 10.1177/10781552221122782

By:

Tezcan, Songul;
Tanır, Gökçen İlke;
Yılmaz, Hayriye;
Memiş, Semra;
Yumuk, Perran Fulden;
Apikoğlu, Şule

Publication type:

Article

Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1381, doi. 10.1177/10781552221122058

By:

Mathers, Brittney;
Abadi, Shirin;
Davies, Janine M;
McIntyre, Connor;
Ho, Cheryl

Publication type:

Article

Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1374, doi. 10.1177/10781552221122051

By:

Liu, Hui-Lin;
Chuang, Cheng-Hao;
Chen, Chin-Ling;
Wei, Po-Ju;
Yang, Chih-Jen

Publication type:

Article

Impact of oral chemotherapy pharmacists on cost avoidance of oral oncolytics in an integrated health system.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1369, doi. 10.1177/10781552221122034

By:

Nguyen, Analia L

Publication type:

Article

Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1361, doi. 10.1177/10781552221122026

By:

Eliasen, Astrid;
Kornholt, J;
Mathiasen, R;
Brok, J;
Rechnitzer, C;
Schmiegelow, K;
Dalhoff, K

Publication type:

Article

Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1343, doi. 10.1177/10781552221119797

By:

Chung, Clement;
Yeung, Vanessa T.Y.;
Wong, Kenneth C.W.

Publication type:

Article

Contribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1334, doi. 10.1177/10781552221118846

By:

Cherif Chefchaouni, Ali;
Boudina, Yassine;
Chennaq, Meryem;
Belahcen, Mohammed Jaouad;
Rahali, Younes

Publication type:

Article

Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1326, doi. 10.1177/10781552221118635

By:

Abernathy, Karin M;
Perciavalle, Matthew A;
Gatwood, Katie S;
Chen, Heidi;
Zakhari, Matthew M;
Byrne, Michael

Publication type:

Article

Effectiveness of antiemetic in reducing chemotherapy-induced nausea and vomiting in adult patients; An oncology center experience.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1317, doi. 10.1177/10781552221118634

By:

Al-Salloum, Haya F;
AL-Harbi, Hayat Eid;
Abdelazeem, Ahmed

Publication type:

Article

Protective effects of Panax ginseng against doxorubicin-induced cardiac toxicity in patients with non-metastatic breast cancer: A randomized, double-blind, placebo-controlled clinical trial.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1306, doi. 10.1177/10781552221118530

By:

Hamidian, Malihe;
Foroughinia, Farzaneh;
Haghighat, Shirin;
Attar, Armin;
Haem, Elham

Publication type:

Article

Impact of single-nucleotide variants and nutritional status on population pharmacokinetics of Doxorubicin, and its effect on cardiotoxicity in children with leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1290, doi. 10.1177/10781552221117810

By:

Gándara-Mireles, Jesús Alonso;
Lares-Asseff, Ismael;
Reyes Espinoza, Elio Aarón;
Fierro, Ignacio Villanueva;
Castañeda, Verónica Loera;
Cordova Hurtado, Lourdes Patricia;
González, Carla Díaz;
Romero, Leslie Patrón;
Reyes, Horacio Almanza

Publication type:

Article

Corrigendum to Role of sacituzumab govitecan in solid tumors.

Published in:: 2023
Publication type:: Correction Notice

Erratum to Evaluation of antibiotic appropriateness at an outpatient oncology centre.

Published in:: 2023
Publication type:: Correction Notice